Assessing early recovery after endovascular treatment for acute stroke
Assessment of Patients' Early Neurological Clinical Recovery, 3 Months After Endovascular Treatment of an Acute Ischemic Stroke
This study looks at how well people recover in the first three months after having a special procedure to treat a stroke, to see if it helps them feel better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Sex | All |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild Research network |
| Locations | 1 site (Paris) |
| Trial ID | NCT02879123 on ClinicalTrials.gov |
What this trial studies
This observational trial collects standardized data on the early neurological recovery of patients three months after they undergo endovascular treatment for acute ischemic stroke. The study focuses on the impact of recanalization techniques, such as thrombectomy, on patient outcomes. By evaluating the clinical recovery at this critical follow-up stage, the trial aims to provide insights into the effectiveness of current treatment strategies. The findings could help improve patient management and inform future therapeutic approaches.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have experienced an acute ischemic stroke and received endovascular treatment.
Not a fit: Patients who have not undergone endovascular treatment for their stroke may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of recovery trajectories after stroke treatment, leading to improved patient care.
How similar studies have performed: Other studies have shown success with similar approaches in evaluating recovery outcomes after stroke treatments.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * acute ischemic stroke * endovascular treatment Exclusion Criteria: * none
Where this trial is running
Paris
- Fondation Ophtalmologique Adolphe de Rothschild — Paris, France (Recruiting)
Study contacts
- Principal investigator: Raphaël Blanc, MD — Fondation Ophtalmologique Adolphe de Rothschild
- Study coordinator: Raphaël Blanc, MD
- Email: rblanc@for.paris
- Phone: + 33 01 48 03 68 28
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.